Samples: 3 whole blood samples. The scheme contains primarily Plasmodium falciparum positive and negative samples, occasionally other Plasmodium species are included.
Type: Physical sample
Examinations: Antigen and nucleic acid detection. Target antigens: HRP2 and/or pLDH and/or aldolase.
Additional information: For clinical laboratories and POCT sites.
